Company · CIK 0001662579 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
C4 Therapeutics, Inc. · CCCC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 FMForm 4 → | Sep 21, 4:24 pm EDT | Kendra AdamsChief Financial Officer | 9,025 | $3.39 | $9,407 | 382,323 | — | |
| Jul 10, 2026 FMForm 4 → | Jul 13, 4:33 pm EDT | Leonard ReynoChief Medical Officer | 22,722 | $4.06 | $30,032 | 372,406 | — | |
| Jul 1, 2026 AForm 4 → | Jul 2, 4:04 pm EDT | Kenneth Carl AndersonDirector | 2,650 | $4.34 | $11,501 | 71,950 | — | |
| Jul 1, 2026 AForm 4 → | Jul 2, 4:04 pm EDT | Donna Roy GroganDirector | 3,341 | $4.34 | $14,500 | 74,853 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.